Over 10,000 customers have rated this store since 1999
Noni - Vitamins and Supplements
What Is Noni?
Noni Juice has been used by natives of the pacific islands for over 2,000 years. It is only recently that western societies have begun using the plant and its fruit as a natural supplement. What we do know about Noni, based on western science, is that it is a powerful antioxidant; it reduces modification of low-density lipoprotein (LDL) which should lessen the onset of arteriosclerosis; it appears to boost the immunity of people taking it; it appears to have anti-inflammatory properties.
Noni (also known as Indian Mulberry) is a green, lumpy, pocked fruit that is about the size and shape of potato. It is only recently that western societies have begun using the plant and its fruit as a natural supplement. Tahitian Noni Juice, Certified Organic (16 fl.oz and 32 fl.oz) is currently out of stock.
Why Is Our Noni Better?
Our Noni is the best you can get. Period. Organically grown (USDA-certified) in rich Tahitian soil, our liquid Noni is made of fresh fruit extract and infused with Noni leaves (which may have their own medicinal value). Our Noni juice contains 100% Noni juice, nothing else.
Noni is expensive to make. Many manufacturers of Noni sell their product mixed with grape juice and blueberry juice. The addition of fruit juices is primarily done to cut costs, improve flavor and have you pay a high price for water and common fruit juices. That’s silly. Why pay $30 for a bottle of grape juice? Our Noni contains Noni juice and nothing else. Buy our 100% pure, certified-organic Noni from Tahiti and mix it with your own juices at home or better yet, drink it straight. That’s how nature intended it to be consumed.
At Whole Health, we are committed to being your Trusted Name In Natural Health Products™. As a rule, we rely first on double-blind placebo studies for analyzing the efficacy of a supplement. Double-blind placebo studies, supplemented with solid scientific research on the biological and chemical components of a supplement and how it affects the human body combined with In Vitro analysis, are the most reliable form of scientific analysis of efficacy. This is not to say that we disregard the traditional, natural medicine of native cultures. Far from it, most of the herbal supplements consumed today were consumed first by native cultures for medicinal purposes. It was only later, under western scientific analysis, that their critical components were identified and their medical value was proved.
Concerning Noni, the vast majority of the science and knowledge of the fruit is of a traditional basis. Western science of a reliable nature is just now starting to accumulate on Noni and for now most of the traditional medicine claims are unsubstantiated by double-blind placebo studies. Certainly many studies and scientific analyses have shown promising results, particularly In Vitro (laboratory, test tube, Petri dish, etc.), but only time will tell if more rigorous studies prove the medicinal value of Noni.
What we do know about Noni, based on western science, is that:
It is a powerful antioxidant; 1,2,4
It reduces modification of low-density lipoprotein (LDL) which should lessen the onset of arteriosclerosis; 5,12
In Vitro (laboratory, test tube, Petri dish, etc.) tests show that it can slow, stop or reverse the growth of cancer cells; 3,4,6,10,11,15,16,17,21
It appears to boost the immunity of people taking it; 6
It appears to have anti-inflammatory properties; 7,9,12,18
No small thing to be an antioxidant:
Noni is a powerful antioxidant. An antioxidant is a substance that reduces the oxidative damage caused by free radicals.
What are free radicals? Free radicals are unstable atoms or molecules with at least one unpaired electron. These atoms or molecules with unpaired electrons go looking for another electron to pair up with. If they find an electron, they take it. That makes them stable now, but it makes the atoms or molecules that they took the electron from, unstable. This makes for a new, Free Radical. Additionally, the serious damage from Free Radicals seems to come in the act of searching for, piercing into and taking electrons from cells. This “oxidization” activity damages cell structures, particularly the cellular plasma membranes. Plasma cell membranes are natural gate keepers for cells, deciding what comes and goes within the cell. Damaging the plasma cell membrane and/or having the presence of free radicals in the cell, can damage the cell’s ability to generate energy (in the mitochondria organelles), damage the cell’s nucleus and/or damage the cell’s DNA. Through this process the use and movement of nutrients, oxygen, water, waste products and toxins can also be hindered.
So how do we stop, or reduce the activities or impacts of free radicals? The answer is the aforementioned Antioxidants. Antioxidants inhibit the oxidization and/or the reactions that are caused by free radicals and by doing so, limit or stop the effects of Free Radicals.
Numerous scientific studies have concluded that by consuming foods and supplements which are rich in antioxidant properties, the incidence of diseases associated with the consequences of Free Radical oxidization can be reduced. This does not mean that these diseases can be cured, treated or prevented. Rather, it means that in scientific studies, people who consumed significant levels of antioxidants had lower incidences of these diseases including:
Prostate Cancer 22-28
Skin Cancer 29
Colon /Rectal Cancer 30,31
Heart Disease 32-38
Congestive Heart Failure 39
Stroke 40,41
Alcohol Induced Apoptosis or (literally, cell death common in alcoholics) 42
Advanced Macular Degeneration (AMD) 43
and other diseases and symptoms 44.
Why Our Noni?
Our Noni is the best you can get. Period. Organically grown (USDA-certified) in rich Tahitian soil, our liquid Noni is made of fresh fruit extract and infused with Noni leaves (which may have their own medicinal value). It contains 100% Noni juice, nothing else.
Noni is expensive to make. Many manufacturers of Noni sell their product mixed with grape juice and blueberry juice. The addition of fruit juices is primarily done to cut costs, improve flavor and have you pay a high price for water and common fruit juices. That’s silly. Why pay $30 for a bottle of grape juice? Our Noni contains Noni juice and nothing else. Buy our 100% pure, certified-organic Noni from Tahiti and mix it with your own juices at home or better yet, drink it straight. That’s how nature intended it to be consumed.
Taste of Noni:
Several marketers will tell you that Noni tastes good or that many people grow to like the taste. That’s doubtful. It's not terrible, but it's also not something you will sit at home and sip over ice.
It depends on individual preference, but for our money the following tactics will improve Noni taste:
First, refrigerate it. The colder the better;
Second, mix it with pineapple juice or orange juice, it goes down better that way;
Or third, don't mix it, just pour out a couple of tablespoons and down it straight. If you are like most people, this is the way you'll end up taking it. It's not for sipping, to be sure, but it also doesn't taste that bad.
Jagietia GC, Baliga MS, The Evaluation of Nitric Oxide Scavenging Activity of Certain Indian medicinal plants in vitro: a preliminary study. J Med Food. 2004 Fall; 7(3):343:8
Hiramatsu T, Imoto M, Koyano T, Umezawa K. Induction of normal phenotypes in ras-transformed cells by damnacanthal from Morinda citrifolia. Cancer Lett 1993;73:161–6.
Hirazumi A, Furusawa E, Chou SC, Hokama Y. Anticancer activity of Morinda citrifolia (noni) on intraperitoneally implanted Lewis lung carcinoma in syngeneic mice. Proc West Pharmacol Soc 1994;37:145–6.
Hirazumi A, Furusawa E, Chou SC, Hokama Y. Immunomodulation contributes to the anticancer activity of morinda citrifolia (noni) fruit juice. Proc West Pharmacol Soc 1996;39:7–9 .
Kamiya K, TanakaY, Endang H, Umar M, Satake, T. Chemical constituients of Morinda citrifoila fruits inhibit copper-induced low-density lipoprotein oxidation; J Agric Food Chem. 2004 Sep 22;52(19):5843-8.
Wong, D.K. Are immune responses pivotal to cancer patients long term survival? Two clinical case-study reports on the effects of Morinda citrifolia (Noni). Hawaii Med J. 2004 Jun;63(6):182-4.
Younos C, Rolland A, Fleurentin J, et al. Analgesic and behavioural effects of Morinda citrifolia. Planta Med 1990;56:430–4.\
Levand O, Larson HO. Some chemical constituents of Morinda citrifolia. Planta Med 1979;36:186–7.
Hirazumi A, Furusawa E. An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (noni) with antitumour activity. Phytother Res 1999;13:380–7.
Hornick CA , Myers A, Sadowska-Krowicka H, Anthony CT, Woltering EA. Inhibition of angiogenic initiation and disruption of newly established human vascular networks by juice from Morinda citrifolia (Noni). Angiogenesis 2003;6(2):143-9.
Furusawa E, Hirazumi A, Story S, Jenesen J. Antitumor potential of a polysaccharide-rich substance from the fruit juice of Morinda citrifolia (Noni) on sarcoma 180 ascites tumour in mice. Phytother Res. 2003 Dec;17(10):1158-64.
McClatchey W. From Polynesian healers to health food stores: changing perspectives of Morinda citrifolia (Rubiaceae) Intergr Cancer Ther. 2002 Jun;1(2):110-20;discussion 120.
Wang My, West Bj, Jensen CJ, et al. Morinda citrifolia (Noni): a literature review and recent advances in Noni research. Acta Pharmacol Sin. 2002 Dec;23(12):1127-41.
MCKoy ML, Thomas EA, Simor, OR. Preliminary investigation of the anti-inflammatory properties of an aqueous extract from Morinda citrifolia (Noni). Proc West Pharmacol Soc 202;45:76-78.
Saludes JP, Garson MJ, Franzblau SG, Aguinaldo AM. Antitubular constituients from the hexane fraction of Morinda citrifolia linn. (Ribiaceae) Phytother Res. 2002 Nov;16(7):683-5.
Wang MY, Su C. Cancer preventive effect of Morinda citrifolia (Noni) Ann NY Acd. Sci 2001 Dec;952:161-8.
Liu G, Bode A, MA WY, Sang S, HO CT, Dong Z. Two novel glycosides from the fruits of Morinda citrifolia (Noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line. Cancer Res 2001 Aug 1;61(15):5749-56.
Author unknown. Noni Plant May Help TB. Aids Patient Care STDS 2001 Mar;15(3):175.
Wang M, Kikuzaki H, et al. Novel glycosides from Noni (Morinda Citrifolia). Journal of Natural Products Aug;63(8):1182-3.
Wang M, Kikuzaki H, et al. Novel trisaccharide fatty ester identified from fruits of Morinda citrifolia (Noni). Journal of Agric Food Chem 199 Dec;47(12):4880-2.
Hirazumi A, Furusawa E, et al. Anticancer activity of Morinda citrifolia (Noni) on intraperitoneally implanted Lewis lung carcinoma in syngeneic mice Proc West Pharmacol Soc 1994;37:145-6 .
Council on Nutrition of the American Chiropractic Association, 19:13-19, 1996. Hadley CW, Miller EC, Schwartz SJ, Clinton SK. Tomatoes, lycopene, and prostate cancer: progress and promise. Exp Biol Med ( Maywood). Nov 2002;227(10):869-880.
Pastori M, Pfander H, Boscoboinik D, Azzi A. Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells. Biochem Biophys Res Commun. 1998;250(3):582-585.
Gann PH, Khachik F. Tomatoes or lycopene versus prostate cancer: is evolution anti-reductionist? J Natl Cancer Inst. Nov 5 2003;95(21):1563-1565.
Etminan M, Takkouche B, Caamano-Isorna F. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev. Mar 2004;13(3):340-345.
Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Canc Inst. 1995;87:1767-1776.
Chen L, Stacewicz-Sapuntzakis M, Duncan C, et al. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst. 2001;93(24):1872-1879.
Chan JM, Stampfer MJ, Giovannucci E, et al. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science. 1998;279:563-566.
Millen AE, Tucker MA, et. Al. Diet and Melanoma in a Case Control Study, Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):1042-51.
Nkondjock A, Ghadirian P.. Dietary carotenoids and risk of colon cancer: case-control study. Int J Cancer 2004 May 20;110(1):110-6.
Murtaugh MA, Ma KN, et al. Antioxidants, carotenoids, and risk of rectal cancer. Am J Epidemiol. 2004 Jan 1;159(1):32-41
Kohlmeier L, Kark JD, GomezGracia E, et al. Lycopene and myocardial infarction risk in the EURAMIC Study. Am J Epidemiol. 1997;146:618-626 12. Truswell AS. ABC of nutrition. Nutrition for pregnancy. Br Med J 1985;291:263-6.
Klipstein-Grobusch K, Launer LJ, Geleijnse JM, Boeing H, Hofman A, Witteman JC. Serum carotenoids and atherosclerosis. The Rotterdam Study. Atherosclerosis. 2000;148(1):49-56.
Rissanen TH, Voutilainen S, Nyyssonen K, et al. Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr. 2001;85(6):749-754.
Rissanen TH, Voutilainen S, Nyyssonen K, Salonen R, Kaplan GA, Salonen JT. Serum lycopene concentrations and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr. Jan 2003;77(1):133-138.
Kristenson M, Zieden B, Kucinskiene Z, et al. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50. BMJ. 1997;314(7081):629-633.
Sesso HD, Buring JE, Norkus EP, Gaziano JM. Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women. Am J Clin Nutr. Jan 2004;79(1):47-53.
Sesso HD, Liu S, Gaziano JM, Buring JE. Dietary lycopene, tomato-based food products and cardiovascular disease in women. J Nutr. Jul 2003;133(7):2336-2341
Wood N, Johnson RB. The relationship between tomato intake and congestive heart failure risk in periodontitis subjects. J Clin Periodontol. 2004 Jul;31(7):574-80.
Hak, A. Stroke: Journal of the American Heart Association, June 4, 2004; vol 35. News release, American Heart Association.
Hak AE, Ma J, , et al. Prospective Study of Plasma Carotenoids and Tocopherols in Relation to Risk of Ischemic Stroke , Stroke . 2004 Jun 3.
Xu Y, Leo MA, Lieber CS. Lycopene attenuates alcoholic apoptosis in HepG2 cells expressing CYP2E1. Biochem Biophys Res Commun. 2003 Aug 29;308(3):614-8.
Simonelli F, Zarrilli F, Mazzeo S. Serum oxidative and antioxidant parameters in a group of Italian patients with age-related maculopathy. . Clin Chim Acta. 2002 Jun;320(1-2):111-5.
Chew BP, Park JS. Carotenoid action on the immune response . J Nutr. 2004 Jan;134(1):257S-261S.
Fuhrman B, Elias, A, et. al. Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Biophys Res Commun 1997; 233:658-662.
Drs. Keith Ingold and Graham Burton. National Research Council of Canada.
Venket Rao, Department of Nutritional Sciences, Faculty of Medicine, University of Toronto.
Annabi, B., M. P. Lachambre, N. Bousquet-Gagnon, M. Page, D. Gingras and R. Beliveau (2002). "Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells." Biochim Biophys Acta 1542(1-3): 209-20.
Aucamp, J., A. Gaspar, Y. Hara and Z. Apostolides (1997). "Inhibition of xanthine oxidase by catechins from tea (Camellia sinensis)." Anticancer Res 17(6D): 4381-5.
Brown, M. D. (1999). "Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer." Altern Med Rev 4(5): 360-70.
Higashi-Okai, K. and Y. Okai (1998). "Potent suppressive activity of chlorophyll a and b from green tea (Camellia sinensis) against tumor promotion in mouse skin." J Uoeh 20(3): 181-8.
Jodoin, J., M. Demeule and R. Beliveau (2002). "Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols." Biochim Biophys Acta 1542(1-3): 149-59.
Kapadia, G. J., B. D. Paul, E. B. Chung, B. Ghosh and S. N. Pradhan (1976). "Carcinogenicity of Camellia sinensis (tea) and some tannin-containing folk medicinal herbs administered subcutaneously in rats." J Natl Cancer Inst 57(1): 207-9.
Katiyar, S. K., R. Agarwal, Z. Y. Wang, A. K. Bhatia and H. Mukhtar (1992). "(-)-Epigallocatechin-3-gallate in Camellia sinensis leaves from Himalayan region of Sikkim: inhibitory effects against biochemical events and tumor initiation in Sencar mouse skin." Nutr Cancer 18(1): 73-83.
Katiyar, S. K. and H. Mukhtar (1997). "Tea antioxidants in cancer chemoprevention." J Cell Biochem Suppl 27: 59-67.
Kavanagh, K. T., L. J. Hafer, D. W. Kim, K. K. Mann, D. H. Sherr, A. E. Rogers and G. E. Sonenshein (2001). "Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture." J Cell Biochem 82(3): 387-98.
Mukhtar, H., Z. Y. Wang, S. K. Katiyar and R. Agarwal (1992). "Tea components: antimutagenic and anticarcinogenic effects." Prev Med 21(3): 351-60.
Okai, Y. and K. Higashi-Okai (1997). "Potent suppressive activity of nonpolyphenolic fraction of green tea (Camellia sinensis) against genotoxin-induced umu C gene expression in Salmonella typhimurium (TA 1535/pSK 1002), tumor promotor-dependent ornithine decarboxylase induction of BALB/c 3T3 fibroblast cells, and chemically induced mouse skin tumorigenesis." Teratog Carcinog Mutagen 17(6): 305-12.
Sakamoto, K. (2000). "Synergistic effects of thearubigin and genistein on human prostate tumor cell (PC-3) growth via cell cycle arrest." Cancer Lett 151(1): 103-9.
Weisburger, J. H. (1997). "Tea and health: a historical perspective." Cancer Lett 114(1-2): 315-7.
Shim, J. S., M. H. Kang, Y. H. Kim, J. K. Roh, C. Roberts and I. P. Lee (1995). "Chemopreventive effect of green tea (Camellia sinensis) among cigarette smokers." Cancer Epidemiol Biomarkers Prev 4(4): 387-91.
Valcic, S., B. N. Timmermann, D. S. Alberts, G. A. Wachter, M. Krutzsch, J. Wymer and J. M. Guillen (1996). "Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines." Anticancer Drugs 7(4): 461-8.
Yang, C. S., J. Y. Chung, G. Yang, S. K. Chhabra and M. J. Lee (2000). "Tea and tea polyphenols in cancer prevention." J Nutr 130(2S Suppl): 472S-478S.
Yang, C. S., S. Prabhu and J. Landau (2001). "Prevention of carcinogenesis by tea polyphenols." Drug Metab Rev 33(3-4): 237-53.
Hastak, K., S. Gupta, et al. (2003). "Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells." Oncogene 22(31): 4851-9.
Rosengren, R. J. (2003). "Catechins and the treatment of breast cancer: Possible utility and mechanistic targets." IDrugs 6(11): 1073-8
Pilorget, A., V. Berthet, et al. (2003). "Medulloblastoma cell invasion is inhibited by green tea (-)epigallocatechin-3-gallate." J Cell Biochem 90(4): 745-55.
Lambert, J. D. and C. S. Yang (2003). "Mechanisms of cancer prevention by tea constituents." J Nutr 133(10): 3262S-3267S.
Kemberling, J. K., J. A. Hampton, et al. (2003). "Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate." J Urol 170(3): 773-6.
Einspahr, J. G., G. T. Bowden, et al. (2003). "Skin cancer chemoprevention: strategies to save our skin." Recent Results Cancer Res 163: 151-64; discussion 264-6.
Adhami, V. M., N. Ahmad, et al. (2003). "Molecular targets for green tea in prostate cancer prevention." J Nutr 133(7 Suppl): 2417S-2424S.
Ahn, W. S., S. W. Huh, et al. (2003). "A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression." DNA Cell Biol 22(3): 217-24.
Morre, D. J., D. M. Morre, et al. (2003). "Tea catechin synergies in inhibition of cancer cell proliferation and of a cancer specific cell surface oxidase (ECTO-NOX)." Pharmacol Toxicol 92(5): 234-41.
Fujiki, H., M. Suganuma, et al. (2003). "New TNF-alpha releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen." Mutat Res 523-524: 119-25.
Katiyar, S. K. (2003). "Skin photoprotection by green tea: antioxidant and immunomodulatory effects." Curr Drug Targets Immune Endocr Metabol Disord 3(3): 234-42.
Raederstorff, D. G., M. F. Schlachter, et al. (2003). "Effect of EGCG on lipid absorption and plasma lipid levels in rats." J Nutr Biochem 14(6): 326-32.
Miura, Y., T. Chiba, et al. (2001). "Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice." J Nutr 131(1): 27-32.
Osada, K., M. Takahashi, et al. (2001). "Tea catechins inhibit cholesterol oxidation accompanying oxidation of low density lipoprotein in vitro." Comp Biochem Physiol C Toxicol Pharmacol 128(2): 153-64.
Miura, S., J. Watanabe, et al. (1995). "Effects of various natural antioxidants on the Cu(2+)-mediated oxidative modification of low density lipoprotein." Biol Pharm Bull 18(1): 1-4.
Miura, S., J. Watanabe, et al. (1994). "The inhibitory effects of tea polyphenols (flavan-3-ol derivatives) on Cu2+ mediated oxidative modification of low density lipoprotein." Biol Pharm Bull 17(12): 1567-72.
Dulloo, A. G., C. Duret, D. Rohrer, L. Girardier, N. Mensi, M. Fathi, P. Chantre and J. Vandermander (1999). "Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans." Am J Clin Nutr 70(6): 1040-5.
Stratton, S. P., R. T. Dorr, et al. (2000). "The state-of-the-art in chemoprevention of skin cancer." Eur J Cancer 36(10): 1292-7.
Jerome L. Fleg, MD; Hidetaka Hougaku, M.D.; Edward G. Lakatta, M.D.; Mary K. Kemper; Christopher J. Earley, M.D.; and E. Jeffrey Metter, M.D. American Heart Association Scientific Sessions 2001.
Pizzorno, Joseph, ND; Murray, Michael T, Eds. Textbook of Natural Medicine, second ed. Churchill Livingstone, 1999.
Wang, Z., Y. Huang, J. Zou, K. Cao, Y. Xu and J. M. Wu (2002). "Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro." Int J Mol Med 9(1): 77-79.
Abu-Amsha Caccetta, R., V. Burke, T. A. Mori, L. J. Beilin, I. B. Puddey and K. D. Croft (2001). "Red wine polyphenols, in the absence of alcohol, reduce lipid peroxidative stress in smoking subjects." Free Radic Biol Med 30(6): 636-42.
Clifford, A. J., S. E. Ebeler, J. D. Ebeler, N. D. Bills, S. H. Hinrichs, P. L. Teissedre and A. L. Waterhouse (1996). "Delayed tumor onset in transgenic mice fed an amino acid-based diet supplemented with red wine solids." Am J Clin Nutr 64(5): 748-56.
de Vries, J. H., P. C. Hollman, I. van Amersfoort, M. R. Olthof and M. B. Katan (2001). "Red wine is a poor source of bioavailable flavonols in men." J Nutr 131(3): 745-8.
Senault, C., D. Betoulle, G. Luc, P. Hauw, D. Rigaud and F. Fumeron (2000). "Beneficial effects of a moderate consumption of red wine on cellular cholesterol efflux in young men." Nutr Metab Cardiovasc Dis 10(2): 63-9.
Takkouche, B., C. Regueira-Mendez, R. Garcia-Closas, A. Figueiras, J. J. Gestal-Otero and M. A. Hernan (2002). "Intake of wine, beer, and spirits and the risk of clinical common cold." Am J Epidemiol 155(9): 853-8.
Nuttall, S. L., M. J. Kendall, E. Bombardelli and P. Morazzoni (1998). "An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect." J Clin Pharm Ther 23(5): 385-9.
Preuss, H. G., D. Wallerstedt, N. Talpur, S. O. Tutuncuoglu, B. Echard, A. Myers, M. Bui and D. Bagchi (2000). "Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study." J Med 31(5-6): 227-46.
Katsube N, Iwashita K, Tsushida T, Yamaki K, Kobori M. Induction of apoptosis in cancer cells by Bilberry (Vaccinium myrtillus) and the anthocyanins. J Agric Food Chem. 2003 Jan 1;51(1):68-75.
Roy S, Khanna S, Alessio HM, Vider J, Bagchi D, Bagchi M, Sen CK., Anti-angiogenic property of edible berries., Free Radic Res. 2002 Sep;36(9):1023-31.
Bomser J, Madhavi DL, Singletary K, Smith MA. In vitro anticancer activity of fruit extracts from Vaccinium species. Planta Med. 1996 Jun;62(3):212-6.
Ferguson PJ, Kurowska E, Freeman DJ, Chambers AF, Koropatnick DJ. A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr. 2004 Jun;134(6):1529-35.
Seeram NP, Adams LS, Hardy ML, Heber D. Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J Agric Food Chem. 2004 May 5;52(9):2512-7.
Murphy BT, MacKinnon SL, Yan X, Hammond GB, Vaisberg AJ, Neto CC. Identification of triterpene hydroxycinnamates with in vitro antitumor activity from whole cranberry fruit (Vaccinium macrocarpon). J Agric Food Chem. 2003 Jun 4;51(12):3541-5.
Sun J, Chu YF, Wu X, Liu RH. Antioxidant and antiproliferative activities of common fruits. J Agric Food Chem. 2002 Dec 4;50(25):7449-54.
Yan X, Murphy BT, Hammond GB, Vinson JA, Neto CC. Antioxidant activities and antitumor screening of extracts from cranberry fruit (Vaccinium macrocarpon). J Agric Food Chem. 2002 Oct 9;50(21):5844-9.
Kahkonen MP, Hopia AI, Heinonen M. Berry phenolics and their antioxidant activity. J Agric Food Chem. 2001 Aug;49(8):4076-82.
Zheng S, Chen A. Activation of PPARgamma is required for curcumin to induce apoptosisand to inhibit the expression of extracellular matrix genes inhepatic stellate cell in vitro. Biochem J. 2004 Aug 23;Pt.
Aggarwal et al., Inhibition of Growth and Survival of Human Head and Neck Squamous Cell Carcinoma Cells by Curcumin via Modulation of Nuclear Factor-kappaB Signalling. Int J Cancer. 2004 Aug 12;:NA.
Koo JY, Kim HJ, Jung KO, Park KY. Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil. J Med Food. 2004 Summer;7(2):117-21.
Caplan, Michael, M.D., Egan, Marie, M.D., Lukacs, Gergely, M.D, Curcumin, a Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects, Science 2004 304: 600-602.
Berkson, B. M. (1999). "A conservative triple antioxidant approach to the treatment of hepatitis C. Combination of alpha lipoic acid (thioctic acid), silymarin, and selenium: three case histories." Med Klin 94 Suppl 3: 84-9.
Blumenthal, Mark; Busse, Werner R; Goldberg, Alicia; Gruenwald, Joerg, PhD; Hall, Tara; Riggins, Chance W.; Rister, Robert S., Eds, Klein, Sigrid, PhD; Rister, Robert S, Trans, Tyler, VarroE, PhD, ScD. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, 1998.
Lapis, K., A. Jeney, et al. (1986). "Experimental studies on the effect of hepatoprotective compounds." Tokai J Exp Clin Med 11(Suppl): 135-45.
Mourelle, M., P. Muriel, et al. (1989). "Prevention of CCL4-induced liver cirrhosis by silymarin." Fundam Clin Pharmacol 3(3): 183-91.
Murray, Michael, ND; Pizzorno, Joseph, ND. Encyclopedia of Natural Medicine, second ed. Prima Publishing, Rocklin. 1999.
Pizzorno, Joseph, ND; Murray, Michael T, Eds. Textbook of Natural Medicine, second ed. Churchill Livingstone, 1999.
Benda, L., H. Dittrich, et al. (1980). "[The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis (author's transl)]." Wien Klin Wochenschr 92(19): 678-83.
Tanasescu, C., S. Petrea, et al. (1988). "Use of the Romanian product Silimarina in the treatment of chronic liver diseases." Med Interne 26(4): 311-22.
Ferenci, P., B. Dragosics, et al. (1989). "Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver." J Hepatol 9(1): 105-13.
Wellington , K. and B. Jarvis (2001). "Silymarin: a review of its clinical properties in the management of hepatic disorders." BioDrugs 15(7): 465-89.
Packer L Tritschler HJ Wessel K, Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free-Radic-Biol-Med. 1997; 22(1-2): 359-78 1997 0891-5849.
Jacob S Streeper RS Fogt DL Hokama JY Tritschler HJ Dietze GJ Henriksen EJ, The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes. 1996 Aug; 45(8): 1024-9 1996 0012-1797.
Murray, Michael, ND, Pizzorno, Joseph, ND. Encyclopedia of Natural Medicine, second ed. Prima Publishing, Rocklin. 1998.
Merin JP Matsuyama M Kira T Baba M Okamoto T, Alpha-lipoic acid blocks HIV-1 LTR-dependent expression of hygromycin resistance in THP-1 stable transformants. FEBS-Lett. 1996 Sep 23; 394(1): 9-13 1996 0014-5793.
Grieb G, [Alpha-lipoic acid inhibits HIV replication]. Med Monatsschr Pharm 1992 Aug;15(8):243-4. (Article in German).
Bailey, D. M. and B. Davies (2001). "Acute mountain sickness; prophylactic benefits of antioxidant vitamin supplementation at high altitude." High Alt Med Biol 2(1): 21-9.
Dietrich, M., G. Block, M. Hudes, J. D. Morrow, E. P. Norkus, M. G. Traber, C. E. Cross and L. Packer (2002). "Antioxidant supplementation decreases lipid peroxidation biomarker F(2)- isoprostanes in plasma of smokers." Cancer Epidemiol Biomarkers Prev 11(1): 7-13.
Reljanovic, M., G. Reichel, K. Rett, M. Lobisch, K. Schuette, W. Moller, H. J. Tritschler and H. Mehnert (1999). "Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy." Free Radic Res 31(3): 171-9.
Ruhnau, K. J., H. P. Meissner, J. R. Finn, M. Reljanovic, M. Lobisch, K. Schutte, D. Nehrdich, H. J. Tritschler, H. Mehnert and D. Ziegler (1999). "Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy." Diabet Med 16(12): 1040-3.
Sachse, G. and B. Willms (1980). "Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy." Horm Metab Res Suppl 9: 105-7.
Strokov, I. A., N. A. Kozlova, V. Mozolevskii Iu, S. P. Miasoedov and N. N. Iakhno (1999). "[The efficacy of the intravenous administration of the trometamol salt of thioctic (alpha-lipoic) acid in diabetic neuropathy]." Zh Nevrol Psikhiatr Im S S Korsakova 99(6): 18-22.
Ziegler, D. and F. A. Gries (1997). "Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy." Diabetes 46 Suppl 2: S62-6.
Ziegler, D., M. Hanefeld, K. J. Ruhnau, H. P. Meissner, M. Lobisch, K. Schutte and F. A. Gries (1995). "Treatment of symptomatic diabetic peripheral neuropathy with the anti- oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)." Diabetologia 38(12): 1425-33.
Ziegler, D., H. Schatz, F. Conrad, F. A. Gries, H. Ulrich and G. Reichel (1997). "Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie." Diabetes Care 20(3): 369-73.
Moreno , J. A., J. Lopez-Miranda, et al. (2003). "[Effect of phenolic compounds of virgin olive oil on LDL oxidation resistance]." Med Clin (Barc) 120(4): 128-31.
Bisignano, G., A. Tomaino, R. Lo Cascio, G. Crisafi, N. Uccella and A. Saija (1999). "On the in-vitro antimicrobial activity of oleuropein and hydroxytyrosol." J Pharm Pharmacol 51(8): 971-4.
Caruso, D., B. Berra, F. Giavarini, N. Cortesi, E. Fedeli and G. Galli (1999). "Effect of virgin olive oil phenolic compounds on in vitro oxidation of human low density lipoproteins." Nutr Metab Cardiovasc Dis 9(3): 102-7.
Coni, E., R. Di Benedetto, M. Di Pasquale, R. Masella, D. Modesti, R. Mattei and E. A. Carlini (2000). "Protective effect of oleuropein, an olive oil biophenol, on low density lipoprotein oxidizability in rabbits." Lipids 35(1): 45-54.
de la Puerta, R., E. Martinez-Dominguez and V. Ruiz-Gutierrez (2000). "Effect of minor components of virgin olive oil on topical antiinflammatory assays [In Process Citation]." Z Naturforsch [C] 55(9-10): 814-9.
Esti, M., L. Cinquanta and E. La Notte (1998). "Phenolic Compounds in Different Olive Varieties." J Agric Food Chem 46(1): 32-35.
Gonzalez, M., A. Zarzuelo, M. J. Gamez, M. P. Utrilla, J. Jimenez and I. Osuna (1992). "Hypoglycemic activity of olive leaf." Planta Med 58(6): 513-5.
Onderoglu, S., S. Sozer, K. M. Erbil, R. Ortac and F. Lermioglu (1999). "The evaluation of long-term effects of cinnamon bark and olive leaf on toxicity induced by streptozotocin administration to rats." J Pharm Pharmacol 51(11): 1305-12.
Perri, E., A. Raffaelli and G. Sindona (1999). "Quantitation of oleuropein in virgin olive oil by ionspray mass spectrometry-selected reaction monitoring." J Agric Food Chem 47(10): 4156-60.
Petroni, A., M. Blasevich, M. Salami, N. Papini, G. F. Montedoro and C. Galli (1995). "Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil." Thromb Res 78(2): 151-60.
Servili, M., M. Baldioli, R. Selvaggini, A. Macchioni and G. Montedoro (1999). "Phenolic compounds of olive fruit: one- and two-dimensional nuclear magnetic resonance characterization of Nuzhenide and its distribution in the constitutive parts of fruit." J Agric Food Chem 47(1): 12-8.
Visioli, F., G. Bellomo and C. Galli (1998). "Free radical-scavenging properties of olive oil polyphenols." Biochem Biophys Res Commun 247(1): 60-4.
Visioli, F., S. Bellosta and C. Galli (1998). "Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages." Life Sci 62(6): 541-6.
Visioli, F. and C. Galli (1994). "Oleuropein protects low density lipoprotein from oxidation." Life Sci 55(24): 1965-71.
Visioli, F. and C. Galli (2001). "Antiatherogenic Components of Olive Oil." Curr Atheroscler Rep 3(1): 64-67.
Zarzuelo, A., J. Duarte, J. Jimenez, M. Gonzalez and M. P. Utrilla (1991). "Vasodilator effect of olive leaf." Planta Med 57(5): 417-9.
This website and these statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Please consult a properly trained medical practitioner for medical advice.